Business Context and Reporting Period
This Form 8-K filing by LIFECORE BIOMEDICAL, INC. (LFCR) was submitted on March 20, 2024, reporting a significant corporate governance event. The filing addresses the resignation of the company's independent registered public accounting firm, Ernst & Young LLP, effective for the fiscal year ending May 26, 2024.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity figures. It is a current report focused solely on the change in the registrant's certifying accountant.
Material Changes
- Accountant Resignation: Ernst & Young LLP declined to stand for reappointment as the independent auditor for the fiscal year ending May 26, 2024.
- Audit History:
- Fiscal Year Ended May 28, 2023: The financial statement opinion was unqualified (no adverse, disclaimer, or qualified opinions). However, the report on internal control over financial reporting contained an adverse opinion due to material weaknesses.
- Fiscal Year Ended May 29, 2022: The financial statement opinion included an explanatory paragraph regarding the company's ability to continue as a going concern. The report on internal control over financial reporting also contained an adverse opinion due to material weaknesses.
- Disagreements: The company reported no disagreements with Ernst & Young regarding accounting principles, practices, financial statement disclosures, or auditing scope during the relevant periods.
Outlook, Risks, and Management Commentary
- Search for New Auditor: The Company and its Audit Committee have initiated discussions with other independent registered public accounting firms to engage a new auditor.
- Disclosure Commitment: The company will disclose the engagement of the new independent accountant in accordance with SEC rules.
- Internal Control Risks: The filing reiterates the existence of material weaknesses in internal control over financial reporting, which led to adverse opinions in the prior two fiscal years.
Investor Verification Checklist
- Verify the identity and qualifications of the new independent registered public accounting firm once appointed.
- Review the company's progress in remediating the material weaknesses in internal control over financial reporting that resulted in adverse opinions for the fiscal years ended May 29, 2022, and May 28, 2023.
- Monitor future filings for any new disagreements or reportable events between the company and the new auditor.
- Confirm the status of the "going concern" qualification noted in the 2022 audit report to ensure it has been resolved in subsequent periods.